The FTC said it reached an agreement that would end its legal challenge of drugmaker Amgen’s $27.8 billion deal to buy Horizon Therapeutics.
The FTC said it reached an agreement that would end its legal challenge of drugmaker Amgen’s $27.8 billion deal to buy Horizon Therapeutics.